Browse Options

Yeda v. OCNL, Administrative Law Division of the Council of State (Afdeling Bestuursrechtspraak Raad van State), 27 May 2009

The Administrative Law Division of the Council of State holds that the District Court has rightfully found that the Patent Office was not obligated to issue a Supplementary Protection Certificate for the medicinal product cetuximab. Article 73 (1) of the Dutch Patents Act 1995 on indirect infringement, does not in all circumstances protect the patentee against the sale or distribution of cetuximab, an essential means regarding the patented combination of cetuximab and irinotecan.

Click here for the full text of this case. A summary of this case will be posted on http://www.KluwerIPCases.com.

Leave a Response

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Comment Preview

  1. says: